CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) attributable to Manhattan Scientifics, Inc.	$ 463,000	$ (3,987,000)
Net (loss) attributable to noncontrolling interest
Adjustments to reconcile net income/(loss) to net cash provided by (used in) operating activities:
Stock options issued/vested for services		240,000
Depreciation and amortization	428,000	496,000
Treasury stock cancelled and returned to authorized		3,000
Loss on forgiveness of debt	6,739,000
Changes in:
Accounts receivable	30,000
Prepaid expenses and other assets	(3,000)
Accounts payable and accrued expenses	(40,000)	388,000
Accrued interest and expenses, related parties	(1,000)
Deferred revenue
Net cash provided by/(used in) operating activities	7,616,000	(2,860,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Adjustment for noncontrolling interest	(8,758,000)
Reduction of assets due to deconsolidation of noncontrolling interest	696,000
Purchase of fixed assets	(23,000)	(13,000)
Net cash used in investing activities	(8,085,000)	(13,000)
NET INCREASE IN CASH AND CASH EQUIVALENTS	(469,000)	(2,873,000)
Cash and cash equivalents, beginning of year	1,068,000	5,364,000
CASH AND CASH EQUIVALENTS, END OF YEAR	$ 599,000	$ 2,491,000